{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:45:42Z","timestamp":1793857542924,"version":"4.6.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["733100"],"award-info":[{"award-number":["733100"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007949","name":"Swedish Rheumatism Association","doi-asserted-by":"publisher","award":["2024 R-995557"],"award-info":[{"award-number":["2024 R-995557"]}],"id":[{"id":"10.13039\/501100007949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009806","name":"Ulla and Gustaf af Ugglas Foundation","doi-asserted-by":"publisher","award":["2023-025029"],"award-info":[{"award-number":["2023-025029"]}],"id":[{"id":"10.13039\/501100009806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["742390"],"award-info":[{"award-number":["742390"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["EGAS00001007750"],"award-info":[{"award-number":["EGAS00001007750"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["103\/06-03-2014"],"award-info":[{"award-number":["103\/06-03-2014"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007857","name":"Foundation King Gustaf V 80-\u00e5rsfond","doi-asserted-by":"publisher","award":["FAI-2023-1006"],"award-info":[{"award-number":["FAI-2023-1006"]}],"id":[{"id":"10.13039\/501100007857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007435","name":"\u00c5ke Wiberg Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ard.2025.04.006","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:11:24Z","timestamp":1746789084000},"page":"1342-1353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-6966","authenticated-orcid":false,"given":"Dionysis","family":"Nikolopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0331-3910","authenticated-orcid":false,"given":"George","family":"Sentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iasonas","family":"Kitsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9432-1228","authenticated-orcid":false,"given":"Panagiotis","family":"Garantziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemin","family":"Kapsala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2361-0525","authenticated-orcid":false,"given":"Antigone","family":"Pieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Flouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Manolakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrto","family":"Nikoloudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5647-6505","authenticated-orcid":false,"given":"Aggelos","family":"Banos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1274-0909","authenticated-orcid":false,"given":"Katerina","family":"Chavatza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-5395","authenticated-orcid":false,"given":"Ioannis","family":"Parodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Filia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-1406","authenticated-orcid":false,"given":"George","family":"Bertsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonis","family":"Fanouriakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios T.","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ard.2025.04.006_bib0001","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/0961203320908932","article-title":"Evolving phenotype of systemic lupus erythematosus in Caucasians: low incidence of lupus nephritis, high burden of neuropsychiatric disease and increased rates of late-onset lupus in the \u2018Attikon\u2019 cohort","volume":"29","author":"Nikolopoulos","year":"2020","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.ard.2025.04.006_bib0002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0000000000000655","article-title":"Update on the pathogenesis of central nervous system lupus","volume":"31","author":"Nikolopoulos","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.ard.2025.04.006_bib0003","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.30157","article-title":"Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging","volume":"63","author":"Luyendijk","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0004","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-010-1565-4","article-title":"Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center","volume":"32","author":"Padovan","year":"2012","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.ard.2025.04.006_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2025.04.006_bib0006","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1136\/annrheumdis-2021-222069","article-title":"Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis","volume":"81","author":"Frangou","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0007","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12864-023-09275-8","article-title":"Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy","volume":"24","author":"Nikolakis","year":"2023","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ard.2025.04.006_bib0008","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fimmu.2020.00230","article-title":"A novel microglia-specific transcriptional signature correlates with behavioral deficits in neuropsychiatric lupus","volume":"11","author":"Makinde","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000394","article-title":"Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease","volume":"7","author":"Nikolopoulos","year":"2020","journal-title":"Lupus Sci Med"},{"issue":"2","key":"10.1016\/j.ard.2025.04.006_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/annrheumdis-2019-216155","article-title":"In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR\/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment","volume":"79","author":"Adamichou","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.04.006_bib0011","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ard.2025.04.006_bib0012","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes","volume":"42","author":"Liang","year":"1999","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.006_bib0013","first-page":"910","article-title":"Is it primary neuropsychiatric systemic lupus erythematosus? Performance of existing attribution models using physician judgment as the gold standard","volume":"34","author":"Fanouriakis","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2025.04.006_bib0014","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2025.04.006_bib0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/1744666X.2021.1899810","article-title":"Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives","volume":"17","author":"Nikolopoulos","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.ard.2025.04.006_bib0016","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/1529-0131(200110)45:5<419::AID-ART360>3.0.CO;2-X","article-title":"Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation","volume":"45","author":"Ainiala","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ard.2025.04.006_bib0017","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard-2024-225664","article-title":"Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events","volume":"83","author":"Nikolopoulos","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.04.006_bib0018","unstructured":"Babraham Bioinformatics. FastQC: a quality control tool for high throughput sequence data [Internet]. [cited 2023 Dec 23]. Available from: https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"issue":"2","key":"10.1016\/j.ard.2025.04.006_bib0019","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","article-title":"HTSeq\u2014a Python framework to work with high-throughput sequencing data","volume":"31","author":"Anders","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ard.2025.04.006_bib0021","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"10.1016\/j.ard.2025.04.006_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1203848","article-title":"A network-based approach reveals long non-coding RNAs associated with disease activity in lupus nephritis: key pathways for flare and potential biomarkers to be used as liquid biopsies","volume":"14","author":"Sentis","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ard.2025.04.006_bib0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"D1","key":"10.1016\/j.ard.2025.04.006_bib0024","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ard.2025.04.006_bib0025","author":"Thomas","year":"2022","journal-title":"Package \u2018ggraph\u2019"},{"key":"10.1016\/j.ard.2025.04.006_bib0026","first-page":"1695","article-title":"The igraph software package for complex network research","author":"Csardi","year":"2006","journal-title":"InterJournal Complex Systems"},{"issue":"5","key":"10.1016\/j.ard.2025.04.006_bib0027","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ard-2022-223506","article-title":"Microglia activation in the presence of intact blood-brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus","volume":"82","author":"Nikolopoulos","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.04.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186414","article-title":"Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus","volume":"12","author":"Asano","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/acr2.11217","article-title":"Role of serum IL-6 in neuropsychiatric systemic lupus erythematosus","volume":"3","author":"Hirohata","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-024-03085-9","article-title":"Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL\/lpr mouse model of neuropsychiatric lupus","volume":"21","author":"Reynolds","year":"2024","journal-title":"J Neuroinflammation"},{"issue":"2","key":"10.1016\/j.ard.2025.04.006_bib0031","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/art.40764","article-title":"Psychosis in systemic lupus erythematosus: results from an international inception cohort study","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"43","key":"10.1016\/j.ard.2025.04.006_bib0032","doi-asserted-by":"crossref","first-page":"eabo5840","DOI":"10.1126\/sciadv.abo5840","article-title":"ATR-mediated DNA damage responses underlie aberrant B cell activity in systemic lupus erythematosus","volume":"8","author":"Manolakou","year":"2022","journal-title":"Sci Adv"},{"issue":"46","key":"10.1016\/j.ard.2025.04.006_bib0033","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012912","article-title":"The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: a systematic review and meta-analysis","volume":"97","author":"Xu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ard.2025.04.006_bib0034","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus","volume":"324","author":"Group","year":"1991","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrrheum.2009.235","article-title":"Therapy: hydroxychloroquine in SLE: old drug, new perspectives","volume":"6","author":"D\u00f6rner","year":"2010","journal-title":"Nat Rev Rheumat"},{"issue":"3","key":"10.1016\/j.ard.2025.04.006_bib0036","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/rheumatology\/kead249","article-title":"Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab","volume":"63","author":"Palazzo","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.ard.2025.04.006_bib0037","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/art.41621","article-title":"Association of higher hydroxychloroquine blood levels with reduced thrombosis risk in systemic lupus erythematosus","volume":"73","author":"Petri","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0038","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/s41467-019-09598-9","article-title":"The class 3 PI3K coordinates autophagy and mitochondrial lipid catabolism by controlling nuclear receptor PPAR\u03b1","volume":"10","author":"Iershov","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","article-title":"Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement","volume":"56","author":"Cohen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.ard.2025.04.006_bib0040","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.ard.2025.04.006_bib0041","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.4049\/jimmunol.175.12.8312","article-title":"Quigg RJ. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis","volume":"175","author":"Alexander","year":"2005","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0042","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","article-title":"Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement","volume":"56","author":"Cohen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"7878","key":"10.1016\/j.ard.2025.04.006_bib0043","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte-microglia\u2013astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ard.2025.04.006_bib0044","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/1744666X.2023.2162041","article-title":"Avacopan for the treatment of ANCA-associated vasculitis: an update","volume":"19","author":"Osman","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12882-020-01888-5","article-title":"A systematic review of the role of eculizumab in systemic lupus erythematosus-associated thrombotic microangiopathy","volume":"21","author":"Wright","year":"2020","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.ard.2025.04.006_bib0046","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/rheumatology\/keu482","article-title":"EULAR recommendations for neuropsychiatric systemic lupus erythematosus vs usual care: results from two European centres","volume":"54","author":"Pamfil","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.ard.2025.04.006_bib0047","first-page":"1033","article-title":"Rituximab as first-line therapy in severe lupus erythematosus with neuropsychiatric and renal involvement: a case-report and review of the literature","volume":"7","author":"Angeletti","year":"2017","journal-title":"J Clin Case Rep"},{"issue":"4","key":"10.1016\/j.ard.2025.04.006_bib0048","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ard.2025.04.006_bib0049","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/rheumatology\/kex395","article-title":"Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register","volume":"57","author":"McCarthy","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0050","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2025.04.006_bib0051","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ard.2025.04.006_bib0052","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ard-2024-226142","article-title":"CD19-CAR T-cell therapy induces deep tissue depletion of B cells","volume":"84","author":"Tur","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2025.04.006_bib0053","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease\u2014a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:13:57Z","timestamp":1778386437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725008933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0003496725008933"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.006","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}